SS Innovations International, Inc. has secured $18.6 million in new funding from investors. The capital infusion marks a significant development for the company, which specializes in advanced surgical robotic systems. Founded in 2016 by Dr. Sudhir Srivastava, SS Innovations is dedicated to enhancing the accessibility and affordability of robotic surgical procedures worldwide.
The core of SS Innovations' offering is the SSI Mantra, a surgical robotic system designed to be both advanced and cost-effective. Dr. Srivastava's founding vision centers on improving access to robotic surgery through a blend of clinical expertise, patient outreach, and continuous technological development. The company's research and development efforts are consistently focused on delivering innovative surgical technologies that benefit patients globally.
This latest funding round is poised to accelerate SS Innovations' strategic objectives. The $18.6 million investment will be deployed to fuel the company's growth initiatives, including further enhancing its research and development capabilities for the SSI Mantra system. Additionally, the capital is expected to support efforts to expand the system's market reach and scale operations, reinforcing the company's commitment to its mission.
The investment underscores confidence in SS Innovations' approach to making sophisticated surgical robotics more widely available. By focusing on both technological advancement and cost-effectiveness, the company aims to address a critical need in healthcare. SS Innovations International, Inc. plans to leverage this funding to continue its trajectory of innovation and expand its impact on surgical care globally.
